- Baek KH, Lee EJ, Kim YS. Recurrent pregnancy loss: the key potential mechanisms. Trends in molecular medicine 2007; 13(7):310-7.
- Magnus MC, Wilcox AJ, Morken NH, Weinberg CR, Håberg SE. Role of maternal age and pregnancy history in risk of miscarriage: prospective register based study. bmj 2019; 364.
- Gabbai D, Harlev A, Friger M, Steiner N, Sergienko R, Kreinin A, et al. Pregnancy outcomes among patients with recurrent pregnancy loss and uterine anatomic abnormalities. Journal of Perinatal Medicine 2018; 46(7):728-34.
- Ford HB, Schust DJ. Recurrent pregnancy loss: etiology, diagnosis, and therapy. Reviews in obstetrics and gynecology 2009; 2(2):76.
- Africa CW, Nel J, Stemmet M. Anaerobes and bacterial vaginosis in pregnancy: virulence factors contributing to vaginal colonisation. International journal of environmental research and public health 2014; 11(7):6979-7000.
- Bonyadi M, Yasari S, Taghavi S. Association Study of Gsto1 Gene E155del Polymorphism Among Patients with Recurrent Miscarriage from Northwest of Iran. Studies in Medical Sciences 2015; 26(4):320-6.
- Mahmoudabadi FS, Ziaei S, Firoozabadi M, Kazemnejad A. Use of mobile phone during pregnancy and the risk of spontaneous abortion. Journal of Environmental Health Science and Engineering 2015; 13:1-4.
- Arachchillage DR, Makris M. Reply to comment on: inherited thrombophilia and pregnancy complications: should we test?. InSeminars in Thrombosis and Hemostasis 2019; 45(5):555-556. Thieme Medical Publishers.
- Sah AK, Shrestha N, Joshi P, Lakha R, Shrestha S, Sharma L, et al. Association of parental methylenetetrahydrofolate reductase (MTHFR) C677T gene polymorphism in couples with unexplained recurrent pregnancy loss. BMC research notes 2018; 11(1):1-5.
- Jivraj S, Makris M, Saravelos S, Li TC. Pregnancy outcome in women with factor V Leiden and recurrent miscarriage. BJOG: An International Journal of Obstetrics & Gynaecology 2009; 116(7):995-8.
- Adler G, Mahmutbegovic E, Valjevac A, Adler MA, Mahmutbegovic N, Safranow K, et al. Association between-675 ID, 4G/5G PAI-1 gene polymorphism and pregnancy loss: a systematic review. Acta Informatica Medica 2018; 26(3):156.
- Su MT, Lin SH, Chen YC, Kuo PL. Genetic association studies of ACE and PAI-1 genes in women with recurrent pregnancy loss. Thrombosis and haemostasis 2013; 109(01):8-15.
- Jalili M, Asadollahi S, Seifati SM, Ashrafzadeh HR, Ghasemi N. Investigation of the association between eNOS gene promoter polymorphism (-786 T> C) and idiopathic recurrent pregnancy loss in Iranian women; 2020.
- Azzam OA, Mahgoub SS, Farhan SS. Is there an Association Between-2549 Insertion/Deletion Polymorphisms in the Promotor Region of the Gene Encoding for VEGFA as a Risk Factor and the Idiopathic Recurrent Spontaneous Miscarriage in a Sample of Jordanian Women. Prensa Med Argent (Genetics) 2020; 106:3.
- Elenis E, Lindgren KE, Karypidis H, Skalkidou A, Hosseini F, Bremme K, et al. The histidine-rich glycoprotein A1042G polymorphism and recurrent miscarriage: a pilot study. Reproductive Biology and Endocrinology 2014; 12(1):1-7.
- Fan QE, Zhang J, Cui Y, Wang C, Xie Y, Wang Q, et al. The synergic effects of CTLA-4/Foxp3-related genotypes and chromosomal aberrations on the risk of recurrent spontaneous abortion among a Chinese Han population. Journal of human genetics 2018; 63(5):579-87.
- Ober C, Aldrich CL, Chervoneva I, Billstrand C, Rahimov F, Gray HL, et al. Variation in the HLA-G promoter region influences miscarriage rates. The American Journal of Human Genetics 2003; 72(6):1425-35.
- Najafi N, Ali-Reza A, Hajihosseini R, Khodaverdi S, Mohammadi A. Protective Role of ADA* 2 Allele of the Adenosine Deaminase Gene Against Recurrent Spontaneous Abortions in Iranian Women. Iranian Red Crescent Medical Journal 2019; 21(7).
- Li J, Chen Y, Mo S, Nai D. Potential Positive Association between Cytochrome P450 1A1 Gene Polymorphisms and Recurrent Pregnancy Loss: a Meta‐Analysis. Annals of Human Genetics 2017; 81(4):161-73.
- Koutsothanassis C, Agiannitopoulos K, Georgoutsou M, Bampali K, Hatzaki A, Lamnissou K. Genetic variant in the CYP19 gene and recurrent spontaneous abortions. Gene Reports 2017; 6:41-3.
- Spizzo R, Almeida MI, Colombatti A, Calin GA. Long non-coding RNAs and cancer: a new frontier of translational research?. Oncogene 2012; 31(43):4577-87.
- Aznaourova M, Schmerer N, Schmeck B, Schulte LN. Disease-causing mutations and rearrangements in long non-coding RNA gene loci. Frontiers in genetics 2020; 11:527484.
- Cheng J, Meng J, Zhu L, Peng Y. Exosomal noncoding RNAs in Glioma: biological functions and potential clinical applications. Molecular cancer 2020; 19:1-14.
- Lu Y, Li Y, Chai X, Kang Q, Zhao P, Xiong J, et al. Long noncoding RNA HULC promotes cell proliferation by regulating PI3K/AKT signaling pathway in chronic myeloid leukemia. Gene 2017; 607:41-6.
- Che DI, Yang Y, Xu Y, Fang Z, Pi L, Fu L, et al. The lncRNA MALAT1 rs619586 G variant confers decreased susceptibility to recurrent miscarriage. Frontiers in Physiology 2019; 10:385.
- Che D, Huang W, Fang Z, Li L, Wu H, Pi L, et al. The lncRNA CCAT2 rs6983267 G allele is associated with decreased susceptibility to recurrent miscarriage. Journal of Cellular Physiology 2019; 234(11):20577-83.
- Panzitt K, Tschernatsch MM, Guelly C, Moustafa T, Stradner M, Strohmaier HM, et al. Characterization of HULC, a novel gene with striking up-regulation in hepatocellular carcinoma, as noncoding RNA. Gastroenterology 2007; 132(1):330-42.
- Sun XH, Yang LB, Geng XL, Wang R, Zhang ZC. Increased expression of lncRNA HULC indicates a poor prognosis and promotes cell metastasis in osteosarcoma. International journal of clinical and experimental pathology 2015; 8(3):2994.
- Chen S, Wu DD, Sang XB, Wang LL, Zong ZH, Sun KX, et al. The lncRNA HULC functions as an oncogene by targeting ATG7 and ITGB1 in epithelial ovarian carcinoma. Cell Death & Disease 2017; 8(10):e3118-.
- Wang J, Ma W, Liu Y. Long non-coding RNA HULC promotes bladder cancer cells proliferation but inhibits apoptosis via regulation of ZIC2 and PI3K/AKT signaling pathway. Cancer Biomarkers 2017; 20(4):425-34.
- Yan H, Tian R, Zhang M, Wu J, Ding M, He J. High expression of long noncoding RNA HULC is a poor predictor of prognosis and regulates cell proliferation in glioma. OncoTargets and therapy 2017; 10:113.
- Yang J, Yin Z, Li Y, Liu Y, Huang G, Gu C, et al. The identification of long non-coding RNA H19 target and its function in chronic myeloid leukemia. Molecular Therapy-Nucleic Acids 2020; 19:1368-78.
- Peng W, Gao W, Feng J. Long noncoding RNA HULC is a novel biomarker of poor prognosis in patients with pancreatic cancer. Medical oncology 2014; 31:1-7.
- Zhou W, Chen L, Li C, Huang R, Guo M, Ning S, et al. The multifaceted roles of long noncoding RNAs in pancreatic cancer: an update on what we know. Cancer Cell International 2020; 20:1-11.
- Kang M, Sang Y, Gu H, Zheng L, Wang L, Liu C, et al. Long noncoding RNAs POLR2E rs3787016 C/T and HULC rs7763881 A/C polymorphisms are associated with decreased risk of esophageal cancer. Tumor Biology 2015; 36:6401-8.
- Ma J, Xiao Y, Tian B, Chen S, Zhang B, Wu J, et al. Genome-wide analyses of long non-coding RNA expression profiles and functional network analysis in esophageal squamous cell carcinoma. Scientific Reports 2019; 9(1):9162.
- Wang J, Liu X, Wu H, Ni P, Gu Z, Qiao Y, et al. CREB up-regulates long non-coding RNA, HULC expression through interaction with microRNA-372 in liver cancer. Nucleic acids research 2010; 38(16):5366-83.
- Ou ZL, Luo Z, Lu YB. Long non-coding RNA HULC as a diagnostic and prognostic marker of pancreatic cancer. World journal of gastroenterology 2019; 25(46):6728.
- Xian HP, Zhuo ZL, Sun YJ, Liang B, Zhao XT. Circulating long non‑coding RNAs HULC and ZNFX1‑AS1 are potential biomarkers in patients with gastric cancer. Oncology letters 2018; 16(4):4689-98.
- Wang N, Zhong C, Fu M, Li L, Wang F, Lv P, et al. Long non-coding RNA HULC promotes the development of breast cancer through regulating LYPD1 expression by sponging miR-6754-5p. OncoTargets and therapy 2019; 12:10671.
- Yang XJ, Huang CQ, Peng CW, Hou JX, Liu JY. Long noncoding RNA HULC promotes colorectal carcinoma progression through epigenetically repressing NKD2 expression. Gene 2016; 592(1):172-8.
- Fang Z, Yang Y, Xu Y, Mai H, Zheng W, Pi L, et al. LncRNA HULC polymorphism is associated with recurrent spontaneous abortion susceptibility in the Southern Chinese population. Frontiers in Genetics 2019; 10:918.
- Cao C, Bai S, Zhang J, Sun X, Meng A, Chen H. Understanding recurrent pregnancy loss: recent advances on its etiology, clinical diagnosis, and management. Medical Review; 2022.
- Wang Y, Chen F, Zhao M, Yang Z, Li J, Zhang S, et al. The long noncoding RNA HULC promotes liver cancer by increasing the expression of the HMGA2 oncogene via sequestration of the microRNA-186. Journal of Biological Chemistry 2017; 292(37):15395-407.
- Wang BG, Lv Z, Ding HX, Fang XX, Wen J, Xu Q, et al. The association of lncRNA-HULC polymorphisms with hepatocellular cancer risk and prognosis. Gene 2018; 670:148-54.
- Liu T, Liu Y, Wei C, Yang Z, Chang W, Zhang X. LncRNA HULC promotes the progression of gastric cancer by regulating miR-9-5p/MYH9 axis. Biomedicine & Pharmacotherapy 2020; 121:109607.
- Li S, Zhai J, Liu J, Hong Y, Zhao W, Zhao A, et al. BMAL1 facilitates trophoblast migration and invasion via SP1-DNMT1/DAB2IP pathway in recurrent spontaneous abortion. Oncotarget 2017; 8(52):89451-64.
|